Kymera Therapeutics EPS Basic from Discontinued Operations (Quarterly) Analysis

Kymera Therapeutics, Inc. (KYMR)

84.26 +0.26 (+0.32%) USD | NASDAQ | Dec 22, 14:38

View EPS Basic from Discontinued Operations (Quarterly) for KYMR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Discontinued Operations (Quarterly) Benchmarks

Start Trial

Gilead Sciences, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Cytokinetics, Inc.	--
TG Therapeutics, Inc.	--
Protagonist Therapeutics, Inc.	--